Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF

The purpose of the study was to establish the optimal dose of capecitabine (X) to be used within a multicentre, randomised study evaluating the potential roles of oxaliplatin (O) and X in chemonaive patients (pts) with advanced oesophagogastric cancer. Two by two design was used, and pts were random...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumpter, K, Harper-Wynne, C, Cunningham, D, Rao, S, Tebbutt, N, Norman, A R, Ward, C, Iveson, T, Nicolson, M, Hickish, T, Hill, M, Oates, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361798/
https://www.ncbi.nlm.nih.gov/pubmed/15928658
http://dx.doi.org/10.1038/sj.bjc.6602572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361798/
https://www.ncbi.nlm.nih.gov/pubmed/15928658
http://dx.doi.org/10.1038/sj.bjc.6602572

Ejemplares similares